+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spinal Cord Trauma Treatment - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140129

Global Spinal Cord Trauma Treatment Market to Reach $3.5 Billion by 2030

The global market for Spinal Cord Trauma Treatment estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$3.5 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2022-2030. Surgery, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Corticosteroid segment is readjusted to a revised 3.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $779.9 Million, While China is Forecast to Grow at 3.1% CAGR

The Spinal Cord Trauma Treatment market in the U.S. is estimated at US$779.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$606 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 2.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Select Competitors (Total 41 Featured) -

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • BioArctic AB
  • Bioaxone Biosciences Inc.
  • BioTime, Inc.
  • InVivo Therapeutics Holdings Corporation
  • Kringle Pharma Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pharmicell Co., Ltd.
  • ReNetX Bio
  • Vertex Pharmaceuticals Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Spinal Cord Trauma Treatment

What is the estimated value of the Global Market for Spinal Cord Trauma Treatment?

The Global Market for Spinal Cord Trauma Treatment was estimated to be valued at $2.6 Billion in 2022.

What is the growth rate of the Global Market for Spinal Cord Trauma Treatment?

The growth rate of the Global Market for Spinal Cord Trauma Treatment is 3.8%, with an estimated value of $3.5 Billion by 2030.

What is the forecasted size of the Global Market for Spinal Cord Trauma Treatment?

The Global Market for Spinal Cord Trauma Treatment is estimated to be worth $3.5 Billion by 2030.

Who are the key companies in the Global Market for Spinal Cord Trauma Treatment?

Key companies in the Global Market for Spinal Cord Trauma Treatment include Acorda Therapeutics, Inc., Asterias Biotherapeutics, Inc., BioArctic AB, Bioaxone Biosciences Inc., BioTime, Inc., InVivo Therapeutics Holdings Corporation, Kringle Pharma Inc., Novartis AG, Pfizer, Inc. and Pharmicell Co., Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Spinal Cord Trauma Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Spinal Cord Trauma Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Spinal Cord Trauma Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Corticosteroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Corticosteroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Corticosteroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Spinal Traction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Spinal Traction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Spinal Traction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Complete Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Complete Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Complete Spinal Cord Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Partial Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Partial Spinal Cord Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Partial Spinal Cord Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Trauma Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Trauma Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Spinal Cord Trauma Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: USA 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: USA Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: USA 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 32: USA Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: USA Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: USA 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • CANADA
  • Table 35: Canada Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Canada Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: Canada 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 38: Canada Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Canada Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Canada 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 41: Canada Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Canada Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: Canada 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • JAPAN
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 44: Japan Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Japan Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: Japan 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 47: Japan Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Japan Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Japan 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Japan Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Japan 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • CHINA
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 53: China Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: China Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: China 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: China Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: China 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 59: China Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: China Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: China 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • EUROPE
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 62: Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 63: Europe Historic Review for Spinal Cord Trauma Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Europe 16-Year Perspective for Spinal Cord Trauma Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 65: Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Europe Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: Europe 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 68: Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Europe Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: Europe 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 71: Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: Europe Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: Europe 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • FRANCE
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 74: France Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: France Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: France 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 77: France Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: France Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: France 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 80: France Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: France Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: France 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • GERMANY
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 83: Germany Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: Germany Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: Germany 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 86: Germany Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Germany Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: Germany 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 89: Germany Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Germany Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Germany 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • ITALY
  • Table 92: Italy Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Italy Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Italy 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 95: Italy Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Italy Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Italy 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 98: Italy Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 99: Italy Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Italy 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 101: UK Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 102: UK Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 103: UK 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 104: UK Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 105: UK Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 106: UK 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 107: UK Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 108: UK Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 109: UK 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • Table 110: Rest of Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 111: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 112: Rest of Europe 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 113: Rest of Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 114: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 115: Rest of Europe 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 116: Rest of Europe Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 117: Rest of Europe Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 118: Rest of Europe 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Spinal Cord Trauma Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 119: Asia-Pacific Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 120: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by Treatment Type - Surgery, Corticosteroid and Spinal Traction Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 121: Asia-Pacific 16-Year Perspective for Spinal Cord Trauma Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Corticosteroid and Spinal Traction for the Years 2014, 2023 & 2030
  • Table 122: Asia-Pacific Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 123: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by Injury Type - Partial Spinal Cord Injuries and Complete Spinal Cord Injuries Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 124: Asia-Pacific 16-Year Perspective for Spinal Cord Trauma Treatment by Injury Type - Percentage Breakdown of Value Sales for Partial Spinal Cord Injuries and Complete Spinal Cord Injuries for the Years 2014, 2023 & 2030
  • Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 126: Asia-Pacific Historic Review for Spinal Cord Trauma Treatment by End-Use - Hospitals and Trauma Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 127: Asia-Pacific 16-Year Perspective for Spinal Cord Trauma Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals and Trauma Centers for the Years 2014, 2023 & 2030
  • REST OF WORLD
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • BioArctic AB
  • Bioaxone Biosciences Inc.
  • BioTime, Inc.
  • InVivo Therapeutics Holdings Corporation
  • Kringle Pharma Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Pharmicell Co., Ltd.
  • ReNetX Bio
  • Vertex Pharmaceuticals Inc.